The Efficacy of Postoperative Chemotherapy for Patients with Metastatic Brain Tumors from Non-Small Cell Lung Cancer.

about

The Efficacy of Postoperative Chemotherapy for Patients with Metastatic Brain Tumors from Non-Small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q36309766

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@ast

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@en

type

Item

label

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@ast

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@en

prefLabel

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@ast

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@en

P1476

The Efficacy of Postoperative ...... om Non-Small Cell Lung Cancer.

@en

P2093

Heon Yoo

http://www.w3.org/2001/XMLSchema#string

Ho Shin Gwak

http://www.w3.org/2001/XMLSchema#string

Jung Nam Joo

http://www.w3.org/2001/XMLSchema#string

Noah Hong

http://www.w3.org/2001/XMLSchema#string

Sang Hoon Shin

http://www.w3.org/2001/XMLSchema#string

Seung Hoon Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases.

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers

Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer.

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial.

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer.

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.

P304

108-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14791/BTRT.2015.3.2.108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284204543

http://www.w3.org/2001/XMLSchema#string

P698

26605266

http://www.w3.org/2001/XMLSchema#string

P932

4656886

http://www.w3.org/2001/XMLSchema#string